CWG
C WorldWide Group Portfolio holdings
AUM
$7.38B
This Quarter Return
+7.82%
1 Year Return
+18.35%
3 Year Return
+71.53%
5 Year Return
+105.42%
10 Year Return
+360.65%
AUM
$7.79B
AUM Growth
+$7.79B
(+8%)
Cap. Flow
+$127M
Cap. Flow
% of AUM
1.63%
Top 10 Holdings %
Top 10 Hldgs %
71.8%
Holding
138
New
7
Increased
44
Reduced
53
Closed
7
Top Buys
| 1 |
Exxon Mobil
XOM
|
$363M |
| 2 |
Procter & Gamble
PG
|
$151M |
| 3 |
Coca-Cola
KO
|
$22.9M |
| 4 |
AMRN
Amarin Corp
AMRN
|
$11.1M |
| 5 |
HDFC Bank
HDB
|
$9.04M |
Top Sells
| 1 |
Philip Morris
PM
|
$216M |
| 2 |
Citigroup
C
|
$120M |
| 3 |
Visa
V
|
$67.4M |
| 4 |
DexCom
DXCM
|
$6.31M |
| 5 |
KTWO
K2M Group Holdings, Inc
KTWO
|
$5.35M |
Sector Composition
| 1 | Financials | 26.45% |
| 2 | Consumer Discretionary | 18.43% |
| 3 | Healthcare | 14.45% |
| 4 | Communication Services | 13.53% |
| 5 | Consumer Staples | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Exact Sciences
EXAS
$8.98B
| $7.31M | 0.09% | 92,572 -20,127 | -18% | -$1.59M |
|
52
TSMC
TSM
$1.2T
| $6.98M | 0.09% | 157,969 -10,421 | -6% | -$460K |
|
|
HZNP
53
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $6.88M | 0.09% | 351,349 -64,136 | -15% | -$1.26M |
|
54
Alkermes
ALKS
$4.78B
| $6.85M | 0.09% | 161,466 | – | – |
|
55
Dynavax Technologies
DVAX
$1.19B
| $6.77M | 0.09% | 545,715 -249,032 | -31% | -$3.09M |
|
|
AERI
56
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $6.66M | 0.09% | 108,266 -2,572 | -2% | -$158K |
|
|
PTLA
57
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $5.96M | 0.08% | 223,682 +76,095 | +52% | +$2.03M |
|
|
TVRD
58
Tvardi Therapeutics, Inc. Common Stock
TVRD
$281M
| $5.93M | 0.08% | 247,429 -42,521 | -15% | -$1.02M |
|
|
GWPH
59
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $5.89M | 0.08% | 34,088 +2,230 | +7% | +$385K |
|
|
AIMT
60
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $5.68M | 0.07% | 208,182 -38,567 | -16% | -$1.05M |
|
61
Heron Therapeutics
HRTX
$207M
| $5.64M | 0.07% | 178,283 -32,729 | -16% | -$1.04M |
|
62
Hologic
HOLX
$14.9B
| $5.44M | 0.07% | 132,631 +43,754 | +49% | +$1.79M |
|
|
LHCG
63
DELISTED
LHC Group LLC
LHCG
| $5.25M | 0.07% | 51,016 -7,651 | -13% | -$788K |
|
|
64
DexCom
DXCM
$29.5B
| $5.22M | 0.07% | 36,510 -44,093 | -55% | -$6.31M |
|
65
Nektar Therapeutics
NKTR
$568M
| $4.94M | 0.06% | +80,975 | New | +$4.94M |
|
|
PRTK
66
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $4.93M | 0.06% | 508,282 -27,846 | -5% | -$270K |
|
67
Insmed
INSM
$28.8B
| $4.87M | 0.06% | 240,642 -170,312 | -41% | -$3.44M |
|
|
XENT
68
DELISTED
Intersect ENT, Inc
XENT
| $4.81M | 0.06% | 167,333 -2,102 | -1% | -$60.4K |
|
69
Collegium Pharmaceutical
COLL
$1.22B
| $4.71M | 0.06% | 319,750 +171,506 | +116% | +$2.53M |
|
70
Iovance Biotherapeutics
IOVA
$807M
| $4.51M | 0.06% | 400,603 +15,157 | +4% | +$171K |
|
|
DERM
71
DELISTED
Dermira, Inc.
DERM
| $4.45M | 0.06% | 407,771 -73,899 | -15% | -$806K |
|
|
ITCI
72
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $4.31M | 0.06% | 198,703 +25,047 | +14% | +$544K |
|
73
Glaukos
GKOS
$5.5B
| $4.3M | 0.06% | 66,307 -10,894 | -14% | -$707K |
|
74
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $3.76M | 0.05% | 227,896 -39,261 | -15% | -$648K |
|
75
Insulet
PODD
$23.9B
| $3.73M | 0.05% | 35,215 +5,720 | +19% | +$606K |
|